EAM
EFG Asset Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-130,356
| Closed | -$2.23M | – | 177 |
|
|
2025
Q1 | $2.23M | Buy |
130,356
+56,375
| +76% | +$963K | 0.37% | 118 |
|
|
2024
Q4 | $1.83M | Buy |
73,981
+163
| +0.2% | +$4.04K | 0.25% | 161 |
|
|
2024
Q3 | $2.1M | Buy |
73,818
+15,748
| +27% | +$449K | 0.35% | 125 |
|
|
2024
Q2 | $1.53M | Buy |
58,070
+11,000
| +23% | +$290K | 0.27% | 148 |
|
|
2024
Q1 | $1.52M | Buy |
47,070
+20,065
| +74% | +$647K | 0.26% | 154 |
|
|
2023
Q4 | $1.14M | Buy |
+27,005
| New | +$1.14M | 0.22% | 166 |
|